The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Systematic Functional Annotation of Somatic Mutations in Cancer
Open accessAbstract
Summary The functional impact of the vast majority of cancer somatic mutations remains unknown, representing a critical knowledge gap for implementing precision oncology. Here, we report the development of a moderate-throughput functional genomic platform consisting of efficient mutant generation, sensitive viability assays using two growth-factor–dependent cell models, and functional proteomic profiling of signaling effects for select aberrations. We apply the platform to annotate >1000 genomic aberrations, including gene amplifications, point mutations, indels, and gene fusions, potentially doubling the number of driver mutations characterized in clinically actionable genes. Further, the platform is sufficiently sensitive to identify weak drivers. Our data are accessible through a user-friendly, public data portal (http://bioinformatics.mdanderson.org/main/FASMIC). Our study will facilitate biomarker discovery, prediction algorithm improvement, and drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Self-citationHMMER web server: interactive sequence similarity searching
Finn, R. D., Clements, J., & Eddy, S. R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr367 · Cited by 5,952
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Self-citationOncoKB: A Precision Oncology Knowledge Base
Chakravarty, D., Gao, J., Phillips, S., Kundra, R., Zhang, H., Wang, J., Rudolph, J. E., Yaeger, R., Soumerai, T., Nissan, M. H., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00011 · Cited by 2,589
Self-citationLiu, X., Wu, C., Li, C., & Boerwinkle, E. (2016) · Human Mutation · doi:10.1002/humu.22932 · Cited by 983
Chang, M. T., Asthana, S., Gao, S. P., Lee, B. H., Chapman, J. S., Kandoth, C., Gao, J., Socci, N. D., Solit, D. B., Olshen, A. B., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3391 · Cited by 808
Self-citationSNPs, protein structure, and disease
Wang, Z., & Moult, J. (2001) · Human Mutation · doi:10.1002/humu.22 · Cited by 731
Self-citationA generic method for assignment of reliability scores applied to solvent accessibility predictions
Petersen, B., Petersen, T. N., Andersen, P., Nielsen, M., & Lundegaard, C. (2009) · BMC Structural Biology · doi:10.1186/1472-6807-9-51 · Cited by 618
A pan-cancer proteomic perspective on The Cancer Genome Atlas
Akbani, R., Ng, P. K. S., Werner, H. M. J., Shahmoradgoli, M., Zhang, F., Ju, Z., Liu, W., Yang, J.-Y., Yoshihara, K., Li, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4887 · Cited by 607
Self-citationIdentifying Mendelian disease genes with the Variant Effect Scoring Tool
Carter, H., Douville, C., Stenson, P. D., Cooper, D. N., & Karchin, R. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s3-s3 · Cited by 563
Self-citationComprehensive identification of mutational cancer driver genes across 12 tumor types
Tamborero, D., Gonzalez-Perez, A., Perez-Llamas, C., Deu-Pons, J., Kandoth, C., Reimand, J., Lawrence, M. S., Getz, G., Bader, G. D., Ding, L., et al. (2013) · Scientific Reports · doi:10.1038/srep02650 · Cited by 484
Self-citationCheung, L. W. T., Hennessy, B. T., Li, J., Yu, S., Myers, A. P., Djordjevic, B., Lu, Y., Stemke-Hale, K., Dyer, M. D., Zhang, F., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0039 · Cited by 470
Self-citation3Dmol.js: molecular visualization with WebGL
Rego, N., & Koes, D. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu829 · Cited by 362
Oncogenic ERBB3 mutations in human cancers.
Jaiswal, B. S., Kljavin, N. M., Stawiski, E. W., Chan, E., Parikh, C., Durinck, S., Chaudhuri, S., Pujara, K., Guillory, J., Edgar, K. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.012 · Cited by 350
Liang, H., Cheung, L. W. T., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., Dogruluk, T., Lu, Y., Liu, X., Gu, C., et al. (2012) · Genome Research · doi:10.1101/gr.137596.112 · Cited by 241
Self-citationBa/F3 cells and their use in kinase drug discovery
Warmuth, M., Kim, S., Gu, X.-J., Xia, G., & Adrián, F. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011a25f · Cited by 240
3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets
Gao, J., Chang, M. T., Johnsen, H. C., Gao, S. P., Sylvester, B. E., Sumer, S. O., Zhang, H., Solit, D. B., Taylor, B. S., Schultz, N., et al. (2017) · Genome Medicine · doi:10.1186/s13073-016-0393-x · Cited by 217
Self-citationKohsaka, S., Nagano, M., Ueno, T., Suehara, Y., Hayashi, T., Shimada, N., Takahashi, K., Suzuki, K., Takamochi, K., Takahashi, F., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan6566 · Cited by 210
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays
Li, J., Zhao, W., Akbani, R., Liu, W., Ju, Z., Ling, S., Vellano, C. P., Roebuck, P., Yu, Q., Eterovic, A. K., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.005 · Cited by 209
Self-citationHigh-throughput phenotyping of lung cancer somatic mutations
Berger, A. H., Brooks, A. N., Wu, X., Shrestha, Y., Chouinard, C., Piccioni, F., Bagul, M., Kamburov, A., Imielinski, M., Hogstrom, L., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.022 · Cited by 192
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles
Kim, E., Ilic, N., Shrestha, Y., Zou, L., Kamburov, A., Zhu, C., Yang, X., Lubonja, R., Tran, N., Nguyen, C., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0160 · Cited by 169
Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
Dogruluk, T., Tsang, Y. H., Espitia, M., Chen, F., Chen, T., Chong, Z., Appadurai, V., Dogruluk, A., Eterovic, A. K., Bonnen, P. E., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1654 · Cited by 168
Self-citationCRAVAT: cancer-related analysis of variants toolkit
Douville, C. B., Carter, H. K., Kim, R., Niknafs, N., Diekhans, M., Stenson, P. D., Cooper, D. N., Ryan, M., & Karchin, R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt017 · Cited by 160
Self-citationEdgotype: a fundamental link between genotype and phenotype
Sahni, N., Yi, S. S., Zhong, Q., Jailkhani, N., Charloteaux, B., Cusick, M. E., & Vidal, M. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.002 · Cited by 153
Self-citationProtein-structure-guided discovery of functional mutations across 19 cancer types
Niu, B., Scott, A. D., Sengupta, S., Bailey, M. H., Batra, P., Ning, J., Wyczalkowski, M. A., Liang, W.-W., Zhang, Q., McLellan, M. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3586 · Cited by 142
Self-citationCanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features
Mao, Y., Chen, H., Liang, H., Meric‐Bernstam, F., Mills, G. B., & Chen, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077945 · Cited by 126
Self-citationCHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer
Wong, W. C., Kim, D., Carter, H. K., Diekhans, M., Ryan, M., & Karchin, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr357 · Cited by 125
Self-citationExome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
Tokheim, C. J., Bhattacharya, R., Niknafs, N., Gygax, D. M., Kim, R., Ryan, M. T., Masica, D. L., & Karchin, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3190 · Cited by 124
Self-citationFunctional variomics and network perturbation: connecting genotype to phenotype in cancer
Yi, S. S., Lin, S., Li, Y., Zhao, W., Mills, G. B., & Sahni, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.8 · Cited by 107
Self-citationCheung, L. W. T., Yu, S., Zhang, D., Li, J., Ng, P. K., Panupinthu, N., Mitra, S., Ju, Z., Yu, Q., Liang, H., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.08.017 · Cited by 105
Self-citationPI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α
Thorpe, L. M., Spangle, J. M., Ohlson, C. E., Cheng, H.-L. M., Roberts, T. M., Cantley, L. C., & Zhao, J. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704706114 · Cited by 105
Bustamante, C. D., Townsend, J. P., & Hartl, D. L. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026310 · Cited by 100
Functional annotation of rare gene aberration drivers of pancreatic cancer
Tsang, Y. H., Dogruluk, T., Tedeschi, P. M., Wardwell‐Ozgo, J., Lu, H., Espitia, M., Nair, N. V., Minelli, R., Chong, Z., Chen, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms10500 · Cited by 84
Self-citationComparison of algorithms for the detection of cancer drivers at subgene resolution
Porta‐Pardo, E., Kamburov, A., Tamborero, D., Pons, T., Grases, D., Valencia, A., López-Bigas, N., Getz, G. A., & Godzik, A. (2017) · Nature Methods · doi:10.1038/nmeth.4364 · Cited by 75
MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures
Niknafs, N., Kim, D., Kim, R., Diekhans, M., Ryan, M., Stenson, P. D., Cooper, D. N., & Karchin, R. (2013) · Human Genetics · doi:10.1007/s00439-013-1325-0 · Cited by 67
Self-citationLu, H., Villafañe, N., Dogruluk, T., Grzeskowiak, C. L., Kong, K., Tsang, Y. H., Zagorodna, O., Pantazi, A., Yang, L., Neill, N. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2745 · Cited by 42
Self-citation“Personalized Cancer Therapy”: A Publicly Available Precision Oncology Resource
Kurnit, K. C., Bailey, A. M., Zeng, J., Johnson, A. M., Shufean, M. A., Brusco, L., Litzenburger, B. C., Sánchez, N., Khotskaya, Y. B., Holla, V. R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0341 · Cited by 42
Self-citationMutationmapper: A Tool to Aid the Mapping of Protein Mutation Data
Vohra, S., & Biggin, P. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071711 · Cited by 36
Neomorphic mutations create therapeutic challenges in cancer
Takiar, V., Ip, C. K. M., Gao, M., Mills, G. B., & Cheung, L. W. T. (2016) · Oncogene · doi:10.1038/onc.2016.312 · Cited by 34
Self-citationWatanabe‐Smith, K., Godil, J. A., Agarwal, A., Tognon, C. E., & Druker, B. J. (2017) · Oncotarget · doi:10.18632/oncotarget.15392 · Cited by 16
Functionally Assessing Candidate Drivers Advances Precision Cancer Medicine
Scott, K. L., & Powers, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.011 · Cited by 1
Self-citation
Cited by
Comprehensive Characterization of Cancer Driver Genes and Mutations
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,256
Self-citationPI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Peng, Y., Wang, Y., Zhou, C., Mei, W., & Zeng, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.819128 · Cited by 763
Accurate and efficient detection of gene fusions from RNA sequencing data
Uhrig, S., Ellermann, J., Walther, T., Burkhardt, P., Fröhlich, M., Hutter, B., Toprak, U. H., Neumann, O., Stenzinger, A., Scholl, C., et al. (2021) · Genome Research · doi:10.1101/gr.257246.119 · Cited by 526
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Song, T. L., Nairismägi, M.-L., Laurensia, Y., Lim, J.-Q., Tan, J., Li, Z.-M., Pang, W.-L., Kizhakeyil, A., Wijaya, G.-C., Huang, D.-C., et al. (2018) · Blood · doi:10.1182/blood-2018-01-829424 · Cited by 326
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis
Yu, K., Lin, C.-C. J., Hatcher, A., Lozzi, B., Kong, K., Huang-Hobbs, E., Cheng, Y.-T., Beechar, V. B., Zhu, W., Zhang, Y., et al. (2020) · Nature · doi:10.1038/s41586-020-1952-2 · Cited by 253
Self-citation
Metadata
- Authors
- Ng, P. K.-S., Li, J., Jeong, K. J., Shao, S., Chen, H., Tsang, Y. H., Sengupta, S., Wang, Z., Bhavana, V. H., Tran, R., Soewito, S., Minussi, D. C., Moreno, D., Kong, K., Dogruluk, T., Lu, H., Gao, J., Tokheim, C., Zhou, D. C., Johnson, A. M., Zeng, J., Ip, C. K. M., Ju, Z., Wester, M., Yu, S., Li, Y., Vellano, C. P., Schultz, N., Karchin, R., Ding, L., Lu, Y., Cheung, L. W. T., Chen, K., Shaw, K. R., Meric-Bernstam, F., Scott, K. L., Yi, S., Sahni, N., Liang, H., & Mills, G. B.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 33
- Issue
- 3
- Pages
- 450-462.e10
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2790516087
- Cited by
- 335
- References
- 41
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.